Morgan Stanley reiterated coverage on Repare Therapeutics with a new price target

4/19/21 11:06:53 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Morgan Stanley reiterated coverage of Repare Therapeutics with a rating of Overweight and set a new price target of $45.00 from $41.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$RPTX

Date	Price Target	Rating	Analyst
6/9/2023	$11.00 → $16.00	Hold → Buy	Stifel
2/3/2023	$28.00 → $15.00	Overweight → Equal-Weight	Morgan Stanley
1/6/2023	$28.00	Overweight	CapitalOne
4/12/2022	$11.00	Buy → Hold	Stifel
3/17/2022	$43.00	Buy	Goldman
9/23/2021	$48.00	Buy	Stifel
9/13/2021	$54.00	Buy	HC Wainwright & Co.
8/16/2021	$45.00 → $47.00	Overweight	Morgan Stanley